This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24/7 Access
Digital & In-Person

John Dodd, Ph.D.
Vice President, Preclinical Development at Palatin Technologies, Inc.

Agenda Sessions

  • PL8177 OCD - Alignment of Receptor, Oral Formulation and Peptide for Maximal Therapeutic Ratio in IBD

    On Demand - Premium Only